Read More Apparatus Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For Mar 25, 2025
Read More Apparatus New Lymphoma Drug Approved! Half Of The Patients Had Significant Tumour Regression Apr 09, 2025
Read More Medical Neratinib Included In NCCN Guidelines For Specific HER2-Negative Breast Cancers Apr 11, 2025
Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! Apr 08, 2025
